We aimed to determine the agreement between quantitative susceptibility mapping (QSM)‐based biomagnetic liver susceptometry (BLS) and confounder‐corrected R2* mapping with superconducting quantum interference device (SQUID)‐based biomagnetic liver susceptometry in patients… Click to show full abstract
We aimed to determine the agreement between quantitative susceptibility mapping (QSM)‐based biomagnetic liver susceptometry (BLS) and confounder‐corrected R2* mapping with superconducting quantum interference device (SQUID)‐based biomagnetic liver susceptometry in patients with liver iron overload.
               
Click one of the above tabs to view related content.